Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel

References

• Dou J, Zhang H, Liu X, et al. Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration. Colloid Surf B 2014;114:20–7.
   PubMed Web of Science ®Google Scholar
• Yin YM, Cui FD, Mu CF, et al. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release 2009;140:86–94.
   PubMed Web of Science ®Google Scholar
• Hu KL, Cao S, Hu FQ, Feng JF. Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation. Int J Nanomed 2012;7:3537–45.
   PubMed Web of Science ®Google Scholar
• Dong Y, Ng WK, Shen S, et al. Solid lipid nanoparticles: continuous and potential large-scale nanoprecipitation production in static mixers. Colloid Surf B 2012;94:68–72.
   PubMed Web of Science ®Google Scholar
• Finke JH, Schmolke H, Klages CP, Müller-Goymanna CC. Controlling solid lipid nanoparticle adhesion by polyelectrolyte multilayer surface modifications. Int J Pharm 2013;449:59–71.
   PubMed Web of Science ®Google Scholar
• Luo Y, Teng Z, Li Y, Wang Q. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Carbohydr Polym 2015;20:221–9.
   Web of Science ®Google Scholar
• Shi LL, Cao Y, Zhu XY, et al. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model. Int J Pharm 2015;478:60–9.
   PubMed Web of Science ®Google Scholar
• Christophersen PC, Zhang L, Müllertz A, et al. Solid lipid particles for oral delivery of peptide and protein drugs II – the digestion of trilaurin protects desmopressin from proteolytic degradation. Pharm Res 2014;31:2420–8.
   PubMed Web of Science ®Google Scholar
• Ibrahim WM, Alomrani AH, Yassin AE. Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability. Int J Nanomed 2014;9:129–44.
   PubMed Web of Science ®Google Scholar
• Aji Alex MR, Chacko AJ, Jose S, Souto EB. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci 2011;42:11–18.
   PubMed Web of Science ®Google Scholar
• Attili-Qadri S, Karra N, Nemirovski A, et al. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption. Proc Natl Acad Sci 2013;110:17498–503.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Park JW, Yoon IS, Kim DD. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int J Nanomed 2014;9:495–504.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, et al. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine-UK 2009;5:184–91.
   PubMed Web of Science ®Google Scholar
• Venishetty VK, Chede R, Komuravelli R, et al. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Colloid Surf B 2012;95:1–9.
   PubMed Web of Science ®Google Scholar
• Fan T, Chen C, Guo H, et al. Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs. Eur J Pharm Biopharm 2014;88:518–28.
   PubMed Web of Science ®Google Scholar
• Chakravarthi SS, Robinson DH. Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles. Int J Pharm 2011;409:111–20.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen Y, Dahmani FZ, et al. Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel. Biomaterials 2014;35:7654–65.
   PubMed Web of Science ®Google Scholar
• Rosenthal R, Günzel D, Finger C, et al. The effect of chitosan on transcellular and paracellular mechanisms in the intestinal epithelial barrier. Biomaterials 2012;33:2791–800.
   PubMed Web of Science ®Google Scholar
• Yeh TH, Hsu LW, Tseng MT, et al. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials 2011;32:6164–73.
   PubMed Web of Science ®Google Scholar
• Luo QH, Zhao JM, Zhang XR, Pan WS. Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm 2011;403:185–91.
   PubMed Web of Science ®Google Scholar
• Chen D, Xia D, Zhu Q, et al. Comparative study of Pluronic® F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats. Int J Pharm 2013;449:1–9.
   PubMed Web of Science ®Google Scholar
• Fonte P, Nogueira T, Gehm C, et al. Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin. Drug Deliv Transl Res 2011;1:299–308.
   PubMed Web of Science ®Google Scholar
• Kowapradit J, Apirakaramwong A, Ngawhirunpat T, et al. Methylated N-(4-N, N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery. Eur J Pharm Sci 2012;47:359–66.
   PubMed Web of Science ®Google Scholar
• Qiang F, Shin HJ, Lee BJ, Han HK. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Int J Pharm 2012;430:161–6.
   PubMed Web of Science ®Google Scholar
• Li GF, Wang JC, Feng XM, et al. Preparation and testing of quaternized chitosan nanoparticles as gene delivery vehicles. Appl Biochem Biotechnol 2015;175:3244–57.
   PubMed Web of Science ®Google Scholar
• Gursoy N, Garrigue JS, Razafindratsita A, et al. Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system. J Pharm Sci 2003;92:2411–18.
   PubMed Web of Science ®Google Scholar
• Tahara K, Sakai T, Yamamoto H, et al. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int J Pharm 2009;382:198–204.
   PubMed Web of Science ®Google Scholar
• Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm 2011;77:275–82.
   PubMed Web of Science ®Google Scholar
• Zhao G, Huang J, Xue K, et al. Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibition. Eur J Pharm Sci 2013;50:429–39.
   PubMed Web of Science ®Google Scholar
• Mo R, Jin X, Li N, et al. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials 2011;32:4609–20.
   PubMed Web of Science ®Google Scholar
• Petit B, Bouchemal K, Vauthier C, et al. The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticle on mucoadhesion due to pluronic F68 addition. Pharm Res 2012;29:943–52.
   PubMed Web of Science ®Google Scholar